CA SB39

Extends the ban on boric acid in cosmetic products from January 1, 2027 to January 1, 2035 specifically for vaginal suppositories, allowing continued sale of these products used to treat recurrent vaginal yeast and bacterial infections

Requires vaginal suppository products containing boric acid to include a warning label starting January 1, 2027, advising consumers not to use during pregnancy, while trying to conceive, or nursing, and to consult a doctor before use

Exempts vaginal suppository products from both the labeling requirement and the 2035 ban if the product becomes regulated as a drug by the U.S. Food and Drug Administration

Declares the bill an urgency statute taking immediate effect upon approval (October 1, 2025) to ensure women have access to necessary medical and hygiene materials

Acknowledges intravaginal boric acid is recommended by the American College of Obstetricians and Gynecologists and CDC guidelines as one of few treatment options for azole-resistant and recurring vaginal infections